Novartis – Newsemia

STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges

NewsemiaJuly 3, 2020

by NewsemiaJuly 3, 202000

And so, another working week will soon come to an end. Not a moment too soon, yes? For those who think this may sound premature,...

Latest News

European Antibiotics Market Assessment and Forecast to 2027 with Profiles of GlaxoSmithKline, Sanofi, Novartis, Bayer and Pfizer – ResearchAndMarkets.com

NewsemiaJuly 2, 2020

by NewsemiaJuly 2, 202000

DUBLIN–(BUSINESS WIRE)–The “Europe Antibiotics Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country” report has been added...

Latest News

Novartis agrees to $642mn US settlement over kickbacks

NewsemiaJuly 2, 2020

by NewsemiaJuly 2, 202000

Swiss pharmaceutical giant Novartis has agreed to pay more than $642 million to settle a lawsuit which accused it of paying kickbacks to doctors, among...

Latest News

STAT Plus: Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors

NewsemiaJuly 2, 2020

by NewsemiaJuly 2, 202000

After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle a lawsuit in which the federal government alleged the drug...

Latest News

STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries

NewsemiaJune 27, 2020

by NewsemiaJune 27, 202000

Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by federal authorities of using various former and existing subsidiaries to...

Latest News

Novartis to pay $336 mn in US settlements on bribes

NewsemiaJune 25, 2020

by NewsemiaJune 25, 202000

Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities...

Latest News

Swiss giant Novartis halts COVID-19 hydroxychloroquine study

NewsemiaJune 21, 2020

by NewsemiaJune 21, 202000

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for...

Latest News

World Sickle Cell Day 2020: Novartis Takes Further Steps to Make Sickle Cell Disease a Healthcare Priority in Europe

NewsemiaJune 17, 2020

by NewsemiaJune 17, 202000

BASEL, Switzerland–(BUSINESS WIRE)–STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY Many patients with SCD only live into their 40s and endure unpredictable pain crises...

Latest News

STAT Plus: Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus

NewsemiaApril 20, 2020

by NewsemiaApril 20, 2020037

Good morning, everyone, and welcome to another working week. We hope the weekend offered something of a respite, such as it is. In any event,...

Latest News

Novartis steps up to study of hydroxychloroquine in Covid-19

NewsemiaApril 20, 2020

by NewsemiaApril 20, 2020053

The drug giant Novartis said Monday it would conduct a 450-person study to determine if hydroxychloroquine, the malaria drug touted by many pundits and President...

Latest News

STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works

NewsemiaApril 2, 2020

by NewsemiaApril 2, 2020029

Rise and shine, everyone, another busy day is on the way. How could it be otherwise? Despite empty streets, the usual buzz of activity is...

Latest News

STAT Plus: FDA closes review of Novartis data integrity scandal without punishing the drug maker

NewsemiaApril 1, 2020

by NewsemiaApril 1, 2020039

An embarrassing scandal that Novartis (NVS) endured over data integrity has quietly come to a close, with the Food and Drug Administration instructing the drug...

Latest News

STAT Plus: Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal

NewsemiaMarch 31, 2020

by NewsemiaMarch 31, 2020012

Hello, everyone, and how are you coping this morning? We are doing just fine, thank you, as we continue to adjust to this new world....

Latest News

STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges

NewsemiaMarch 3, 2020

by NewsemiaMarch 3, 2020027

In the latest fallout from a federal probe into generic drug price fixing, the Sandoz unit of Novartis (NVS) agreed to pay $195 million to...

Latest News

STAT Plus: Novartis employee claims she was fired for complaining about incorrect data

NewsemiaFebruary 29, 2020

by NewsemiaFebruary 29, 202003

As Novartis (NVS) geared up to win approval for a new eye medication that was pegged to become a blockbuster, an employee tried to push...

Latest News

STAT Plus: Safety concerns regarding Novartis’ new eye drug boost Regeneron stock

NewsemiaFebruary 24, 2020

by NewsemiaFebruary 24, 2020037

A leading association of eye doctors has warned its members about safety concerns about Novartis’ new eye drug, sending the company’s stock down sharply Monday...

Latest News

STAT Plus: Pharmalittle: Novartis lottery for gene therapy begins amid tough questions; coronavirus vaccine may take a year

NewsemiaFebruary 8, 2020

by NewsemiaFebruary 8, 2020043

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal...

Latest News

STAT Plus: U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment

NewsemiaJanuary 31, 2020

by NewsemiaJanuary 31, 2020026

In an unexpected move, the U.S. Department of Health and Human Services will allow Novartis (NVS) to pay for travel, lodging, and meal expenses for...

Latest News

STAT Plus: Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020031

Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue? Consider the alternatives, after all....

Latest News

Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020025

Zolgensma, the Novartis gene therapy for infants and the world’s most expensive medicine, continues to perform well commercially, bringing in $186 million during the fourth...